<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39625388</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Insights Into the Group of Surgically Resectable But Nonoperable Patients With Colorectal Cancer.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>358</EndPage><MedlinePgn>351-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003580</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of colorectal cancer is expected to increase, particularly among patients with significant frailty and comorbidities. A subgroup of these patients may not be suitable for surgery because of the high risk of postoperative morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to characterize the clinical outcomes, management, social status, and survival of patients deemed nonoperable because of comorbidity and/or frailty.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This was a retrospective cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Overall survival was estimated using the Kaplan-Meier method. The Cox proportional-hazards model was used to estimate HRs and 95% CIs for mortality-associated modifiable risk factors.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients diagnosed with resectable colorectal cancer but deemed nonoperable because of comorbidity and/or frailty by a multidisciplinary team between January 1, 2020, and April 30, 2024, were included in this study.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was to describe the current population, investigate mortality, and explore mortality-related risk factors in the current population.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, 69 of 1667 patients who had colorectal cancer that was potentially resectable but who were deemed nonoperable were included in the study population. The rate of 90-day and 1-year mortality was 20% and 52%, respectively. Three years after the diagnosis, 12% of the patients were alive. At the time of diagnosis, anemia was found in 73% of female patients and 71% of male patients. In addition, 77% of the patients had hypoalbuminemia. Lower albumin levels were associated with poor survival (HR, 0.92; 95% CI, 0.88-0.98; p = 0.007).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The retrospective nature and small sample size inherently limit the generalizability of the study findings.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mortality in the current population was high. However, our findings highlight potential areas for improvement in the management of these patients. See Video Abstract .</AbstractText><AbstractText Label="INFORMACIN SOBRE EL GRUPO DE PACIENTES CON CNCER COLORRECTAL RESECABLES QUIRRGICAMENTE PERO NO OPERABLES" NlmCategory="UNASSIGNED">ANTECEDENTES:Se espera que la incidencia del c&#xe1;ncer colorrectal aumente, en particular entre los pacientes con fragilidad y comorbilidades significativas. Un subgrupo de estos pacientes puede no ser apto para la cirug&#xed;a debido al alto riesgo de morbilidad y mortalidad posoperatorias.OBJETIVO:El objetivo de este estudio fue caracterizar los resultados cl&#xed;nicos, el tratamiento, el estado social y la supervivencia de los pacientes considerados no operables debido a la comorbilidad y/o fragilidad.DISE&#xd1;O:Este fue un estudio de cohorte retrospectivo.ESTABLECIMIENTOS:La supervivencia general se estim&#xf3; utilizando el m&#xe9;todo de Kaplan-Meier. Se utiliz&#xf3; el modelo de riesgos proporcionales de Cox para estimar los cocientes de riesgo y los intervalos de confianza del 95% para los factores de riesgo modificables asociados a la mortalidad.PACIENTES:Se incluyeron en este estudio pacientes diagnosticados con c&#xe1;ncer colorrectal resecable pero considerados no operables debido a la comorbilidad y/o fragilidad por un equipo multidisciplinario entre el 1 de enero de 2020 y el 30 de abril de 2024.PRINCIPALES MEDIDAS DE RESULTADOS:El resultado primario fue describir la poblaci&#xf3;n actual, investigar la mortalidad y explorar los factores de riesgo relacionados con la mortalidad en esta poblaci&#xf3;n.RESULTADOS:Durante el per&#xed;odo del estudio, 69 de 1667 pacientes eran potencialmente resecables pero se los consider&#xf3; no operables y se los incluy&#xf3; en la poblaci&#xf3;n del estudio. La tasa de mortalidad a los 90 d&#xed;as y al a&#xf1;o fue del 20% y del 52%, respectivamente. Tres a&#xf1;os despu&#xe9;s del diagn&#xf3;stico, el 12% de los pacientes estaban vivos. En el momento del diagn&#xf3;stico, se encontr&#xf3; anemia en el 73% de las pacientes femeninas y en el 71% de los pacientes masculinos. Adem&#xe1;s, el 77% de los pacientes ten&#xed;an hipoalbuminemia. Los niveles m&#xe1;s bajos de alb&#xfa;mina se asociaron con una supervivencia deficiente, &#xed;ndice de riesgo de 0,92 (intervalo de confianza del 95%: 0,88-0,98, p = 0,007).LIMITACIONES:La naturaleza retrospectiva y el peque&#xf1;o tama&#xf1;o de la muestra limitan inherentemente la generalizaci&#xf3;n de los hallazgos del estudio.CONCLUSIONES:La mortalidad en la poblaci&#xf3;n actual fue alta. Sin embargo, nuestros hallazgos resaltan &#xe1;reas potenciales para mejoras en el manejo de estos pacientes. (Traducci&#xf3;n-Dr. Felipe Bellolio ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ose</LastName><ForeName>Ilze</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7018-9414</Identifier><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhan</LastName><ForeName>Adile</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eraslan</LastName><ForeName>Sule</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Enise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandersen</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righult</LastName><ForeName>Angelina Astrid</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayhan</LastName><ForeName>Emine Ceren</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Amalie Thomsen</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saqi</LastName><ForeName>Ida Kolukisa</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Colorectal Cancer Group, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39625388</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003580</ArticleId><ArticleId IdType="pii">00003453-990000000-00816</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209&#x2013;249.</Citation></Reference><Reference><Citation>eurostat. Statistics Explained. Ageing Europe&#x2013;statistics on population developments. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Ageing_Europe_-_statistics_on_population_developments#Older_people_.E2.80.94_population_overview . Accessed June 10, 2024.</Citation></Reference><Reference><Citation>Ose I, Rosen AW, Br&#xe4;uner K, et al. The association of postoperative morbidity and age on 5-year survival after colorectal surgery in the elderly population: a nationwide cohort study. Colorectal Dis. 2024;26:899&#x2013;915.</Citation></Reference><Reference><Citation>Van Walree IC, Scheepers E, van Huis-Tanja L, et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019;10:847&#x2013;858.</Citation></Reference><Reference><Citation>Bojesen RD, Dalton SO, Skou ST, et al. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open. 2023;7:zrad134.</Citation></Reference><Reference><Citation>Heger P, Probst P, Wiskemann J, Steindorf K, Diener MK, Mihaljevic AL. A systematic review and meta-analysis of physical exercise prehabilitation in major abdominal surgery (PROSPERO 2017 CRD42017080366). J Gastrointest Surg. 2020;24:1375&#x2013;1385.</Citation></Reference><Reference><Citation>Brierley J, Gospodarowicz MD, Wittekind CT. Oesophagus and oesophagogastric junction. In: Brierley J, Gospodarowicz MD, Wittekind CT, eds. TNM Classification of Malignant Tumors International Union Against Cancer. 8th ed. Oxford, England: Wiley; 2017:57&#x2013;62.</Citation></Reference><Reference><Citation>Kopp VJ. Use of the American Society of Anesthesiologists physical status classification system in research. Anesth Analg. 2013;117:752.</Citation></Reference><Reference><Citation>Azam F, Latif MF, Farooq A, et al. Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2019;12:728&#x2013;736.</Citation></Reference><Reference><Citation>Domenica Cappellini M, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging? Semin Hematol. 2015;52:261&#x2013;269.</Citation></Reference><Reference><Citation>The Danish Colorectal Cancer Group. Klinisk Retningslinjer &#x2502;Kraeft DCCG version 2.0. www.dccg.dk/retningslinjer . Accessed June 15, 2024.</Citation></Reference><Reference><Citation>Hardt J, Pilz L, Magdeburg J, Kienle P, Post S, Magdeburg R. Preoperative hypoalbuminemia is an independent risk factor for increased high-grade morbidity after elective rectal cancer resection. Int J Colorectal Dis. 2017;32:1439&#x2013;1446.</Citation></Reference><Reference><Citation>Jerath A, Austin PC, Wijeysundera DN. Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine. Anesthesiology. 2019;131:84&#x2013;93.</Citation></Reference><Reference><Citation>Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343&#x2013;346.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457.</Citation></Reference><Reference><Citation>Lidder PG, Sanders G, Whitehead E, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery&#x2014;a prospective, randomised, controlled trial. Ann R Coll Surg Engl. 2007;89:418&#x2013;421.</Citation></Reference><Reference><Citation>Wilson MJ, van Haaren M, Harlaar JJ, et al. Long-term prognostic value of preoperative anemia in patients with colorectal cancer: a systematic review and meta-analysis. Surg Oncol. 2017;26:96&#x2013;104.</Citation></Reference><Reference><Citation>Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011&#x2013;1023.</Citation></Reference><Reference><Citation>Hu WH, Eisenstein S, Parry L, Ramamoorthy S. Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: a propensity score matching study. Nutr J. 2019;18:33.</Citation></Reference><Reference><Citation>Haskins IN, Baginsky M, Amdur RL, Agarwal S. Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patients. Clin Nutr. 2017;36:1333&#x2013;1338.</Citation></Reference><Reference><Citation>Mullen MG, Michaels AD, Mehaffey HJ, et al. Risk associated with complications and mortality after urgent surgery vs elective and emergency surgery: implications for defining &#x201c;quality&#x201d; and reporting outcomes for urgent surgery. JAMA Surg. 2017;152:768&#x2013;774.</Citation></Reference><Reference><Citation>Leicher LW, Huisman JF, Van Grevenstein WMU, et al. Colonoscopic-assisted laparoscopic wedge resection for colonic lesions: a prospective multicenter cohort study (LIMERIC-Study). Ann Surg. 2022;275:933&#x2013;939.</Citation></Reference><Reference><Citation>Zwager LW, Bastiaansen BAJ, Van Der Spek BW, et al.; Dutch eFTR Group. Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry. Endoscopy. 2022;54:475&#x2013;485.</Citation></Reference><Reference><Citation>Hartwig MFS, Bulut M, Ravn-Eriksen J, et al. Combined endoscopic and laparoscopic surgery (CELS) for early colon cancer in high-risk patients. Surg Endosc. 2023;37:8511&#x2013;8521.</Citation></Reference><Reference><Citation>Ha RK, Park B, Han KS, et al. Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only. Gastrointest Endosc. 2022;96:1036&#x2013;1046.e1.</Citation></Reference><Reference><Citation>Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874:188447.</Citation></Reference><Reference><Citation>Andr&#xe9; T, Shiu KK, Kim TW, et al.; KEYNOTE-177 Investigators. Pembrolizumab in microsatellite-instability&#x2013;high advanced colorectal cancer. N Engl J Med. 2020;383:2207&#x2013;2218.</Citation></Reference><Reference><Citation>Chalabi M, Fanchi LF, Dijkstra KK, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26:566&#x2013;576.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35982519</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Outcomes of Patients Undergoing Elective Bowel Resection Before and After Implementation of an Anemia Screening and Treatment Program.</ArticleTitle><Pagination><StartPage>1381</StartPage><EndPage>1390</EndPage><MedlinePgn>1381-1390</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000002488</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with anemia undergoing elective colorectal cancer surgery are known to have significantly higher rates of postoperative complications and worse outcomes.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to improve rates of anemia screening and treatment in patients undergoing elective colon and rectal resections through a quality improvement initiative.</AbstractText><AbstractText Label="DESIGN">We compared a historical cohort of patients before implementation of our anemia screening and treatment quality improvement program to a prospective cohort after implementation.</AbstractText><AbstractText Label="SETTINGS">This study was conducted at a tertiary care hospital.</AbstractText><AbstractText Label="PATIENTS">This study included all adult patients with a new diagnosis of colon or rectal cancer without evidence of metastatic disease between 2017 and 2019.</AbstractText><AbstractText Label="INTERVENTIONS">The interventions include the anemia screening and treatment quality improvement program.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome was hospital cost per admission.</AbstractText><AbstractText Label="RESULTS">This study includes a total of 84 patients who underwent elective colon or rectal resection before implementation of our anemia quality improvement project and 88 patients who underwent surgery after. In the preimplementation cohort 44 of 84 patients (55.9%) were anemic compared to 47 of 99 patients (54.7%) in the postimplementation cohort. Rates of screening (25%-86.4%) and treatment (27.8%- 63.8%) were significantly increased in the postimplementation cohort. Mean total cost per admission was significantly decreased in the postimplementation cohort (mean cost $16,827 vs $25,796; p = 0.004); this significant reduction was observed even after adjusting for relevant confounding factors (ratio of means: 0.74; 95% CI, 0.65-0.85). The mechanistic link between treatment of anemia and reductions in cost remains unknown. No significant difference was found in rates of blood transfusion, complications, or mortality between the groups.</AbstractText><AbstractText Label="LIMITATIONS">The study limitation includes before-after design subjected to selection and temporal biases.</AbstractText><AbstractText Label="CONCLUSIONS">We demonstrate the successful implementation of an anemia screening and treatment program. This program was associated with significantly reduced cost per admission. This work demonstrates possible value and benefits of implementation of an anemia screening and treatment program. See Video Abstract at http://links.lww.com/DCR/C15 .RESULTADOS DE LOS PACIENTES SOMETIDOS A RESECCI&#xd3;N INTESTINAL ELECTIVA ANTES Y DESPU&#xc9;S DE LA IMPLEMENTACI&#xd3;N DE UN PROGRAMA DE DETECCI&#xd3;N Y TRATAMIENTO DE ANEMIA.</AbstractText><AbstractText Label="ANTECEDENTES">Se sabe que los pacientes an&#xe9;micos que se someten a una cirug&#xed;a electiva de c&#xe1;ncer colorrectal tienen tasas significativamente m&#xe1;s altas de complicaciones posoperatorias y peores resultados.</AbstractText><AbstractText Label="OBJETIVO">Mejorar las tasas de detecci&#xf3;n y tratamiento de la anemia en pacientes sometidos a resecciones electivas de colon y recto a trav&#xe9;s de una iniciativa de mejora de calidad.</AbstractText><AbstractText Label="DISEO">Comparamos una cohorte hist&#xf3;rica de pacientes antes de la implementaci&#xf3;n de nuestro programa de detecci&#xf3;n de anemia y mejora de la calidad del tratamiento con una cohorte prospectiva despu&#xe9;s de la implementaci&#xf3;n.</AbstractText><AbstractText Label="ENTORNO CLINICO">Hospital de atenci&#xf3;n terciaria.</AbstractText><AbstractText Label="PACIENTES">Todos los pacientes adultos con un nuevo diagn&#xf3;stico de c&#xe1;ncer de colon o recto sin evidencia de enfermedad metast&#xe1;sica entre 2017 y 2019.</AbstractText><AbstractText Label="INTERVENCIONES">Detecci&#xf3;n de anemia y programa de mejora de la calidad del tratamiento.</AbstractText><AbstractText Label="PRINCIPALES MEDIDAS DE RESULTADO">El resultado primario fue el costo hospitalario por ingreso.</AbstractText><AbstractText Label="RESULTADOS">Un total de 84 pacientes se sometieron a resecci&#xf3;n electiva de colon o recto antes de la implementaci&#xf3;n de nuestro proyecto de mejora de calidad de la anemia y 88 pacientes se sometieron a cirug&#xed;a despu&#xe9;s. En la cohorte previa a la implementaci&#xf3;n, 44/84 (55,9 %) presentaban anemia en comparaci&#xf3;n con 47/99 (54,7 %) en la cohorte posterior a la implementaci&#xf3;n. Las tasas de detecci&#xf3;n (25 % a 86,4 %) y tratamiento (27,8 % a 63,8 %) aumentaron significativamente en la cohorte posterior a la implementaci&#xf3;n. El costo total medio por admisi&#xf3;n se redujo significativamente en la cohorte posterior a la implementaci&#xf3;n (costo medio $16 827 vs. $25 796, p = 0,004); esta reducci&#xf3;n significativa se observ&#xf3; incluso despu&#xe9;s de ajustar los factores de confusi&#xf3;n relevantes (proporci&#xf3;n de medias: 0,74, IC del 95 %: 0,65 a 0,85). El v&#xed;nculo mec&#xe1;nico entre el tratamiento de la anemia y la reducci&#xf3;n de costos sigue siendo desconocido. No hubo diferencias significativas en las tasas de transfusi&#xf3;n de sangre, complicaciones o mortalidad entre los grupos.</AbstractText><AbstractText Label="LIMITACIONES">El dise&#xf1;o de antes y despu&#xe9;s est&#xe1; sujeto a sesgos temporales y de selecci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES">Demostramos la implementaci&#xf3;n exitosa de un programa de detecci&#xf3;n y tratamiento de anemia. Este programa se asoci&#xf3; con un costo por admisi&#xf3;n significativamente reducido. Este trabajo demuestra el valor y los beneficios posibles de la implementaci&#xf3;n de un programa de detecci&#xf3;n y tratamiento de la anemia. Consulte Video Resumen en http://links.lww.com/DCR/C15 . (Traducci&#xf3;n- Dr. Francisco M. Abarca-Rendon ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Richard W D</ForeName><Initials>RWD</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwiep</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Western Ontario, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Orillia Soldiers Memorial Hospital, Orillia, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenet</LastName><ForeName>Tori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touchie</LastName><ForeName>Donna L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perelman</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musselman</LastName><ForeName>Reilly</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raiche</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIsaac</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavorn</LastName><ForeName>Kednapa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moloo</LastName><ForeName>Husein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="AssociatedDataset"><RefSource>Dis Colon Rectum. 2022 Nov 1;65(11):1293-1294. doi: 10.1097/DCR.0000000000002583.</RefSource><PMID Version="1">35982523</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="Y">Proctectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>0</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35982519</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000002488</ArticleId><ArticleId IdType="pii">00003453-202211000-00014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1. Published online 2011. https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf?ua=1 . Accessed January 25, 2021.</Citation></Reference><Reference><Citation>Sim YE, Wee HE, Ang AL, Ranjakunalan N, Ong BC, Abdullah HR. Prevalence of preoperative anemia, abnormal mean corpuscular volume and red cell distribution width among surgical patients in Singapore, and their influence on one year mortality. PLoS One. 2017;12:e0182543.</Citation></Reference><Reference><Citation>Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396&#x2013;1407.</Citation></Reference><Reference><Citation>Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg. 2011;212:187&#x2013;194.</Citation></Reference><Reference><Citation>Aydinli HH, Benlice C, Ozuner G, Gorgun E, Abbas MA. Risk factors associated with postoperative morbidity in over 500 colovesical fistula patients undergoing colorectal surgery: a retrospective cohort study from ACS-NSQIP database. Int J Colorectal Dis. 2017;32:469&#x2013;474.</Citation></Reference><Reference><Citation>Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P. Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery. 2001;129:433&#x2013;439.</Citation></Reference><Reference><Citation>Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1:CD005033.</Citation></Reference><Reference><Citation>Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012;256:235&#x2013;244.</Citation></Reference><Reference><Citation>Pang QY, An R, Liu HL. Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis. World J Surg Oncol. 2019;17:7.</Citation></Reference><Reference><Citation>Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57:1347&#x2013;1358.</Citation></Reference><Reference><Citation>Feng S, Greenberg J, Moloo H, Thavorn K, McIsaac DI. Hospital cost associated with anemia in elective colorectal surgery: a historical cohort study. Can J Anaesth. 2019;66:877&#x2013;885.</Citation></Reference><Reference><Citation>Ogrinc G, Davies L, Goodman D, Batalden PB, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process. BMJ Quality and Safety. Online first, September 15, 2015.</Citation></Reference><Reference><Citation>McIsaac DI, Abdulla K, Yang H, et al. Association of delay of urgent or emergency surgery with mortality and use of health care resources: a propensity score-matched observational cohort study. CMAJ. 2017;189:E905&#x2013;E912.</Citation></Reference><Reference><Citation>Trentino KM, Mace H, Symons K, et al. Associations of a preoperative anemia and suboptimal iron stores screening and management clinic in colorectal surgery with hospital cost, reimbursement, and length of stay: a net cost analysis. Anesth Analg. 2021;132:344&#x2013;352.</Citation></Reference><Reference><Citation>Richards T, Baikady RR, Clevenger B, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet. 2020;396:1353&#x2013;1361.</Citation></Reference><Reference><Citation>Moncur A, Chowdhary M, Chu Y, Francis NK. Impact and outcomes of postoperative anaemia in colorectal cancer patients: a systematic review. Colorectal Dis. 2021;23:776&#x2013;786.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34840307</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>IPAA Is More "Desmoidogenic" Than Ileorectal Anastomosis in Familial Adenomatous Polyposis.</ArticleTitle><Pagination><StartPage>1351</StartPage><EndPage>1361</EndPage><MedlinePgn>1351-1361</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000002172</ELocationID><Abstract><AbstractText Label="BACKGROUND">Desmoid disease is a leading cause of morbidity and mortality in patients with familial adenomatous polyposis. Abdominal desmoid disease usually follows total proctocolectomy with IPAA or total abdominal colectomy with ileorectal anastomosis. Sex, extraintestinal manifestations, and a 3'-mutation location have been identified as risk factors, but surgical risk factors are poorly understood. We hypothesized that pouch construction creates a higher risk of desmoid formation due to the increased stretch of the small-bowel mesentery.</AbstractText><AbstractText Label="OBJECTIVE">This study aimed to investigate the surgical risk factors for desmoid formation.</AbstractText><AbstractText Label="DESIGN">This was a retrospective, single-center, registry-based cohort study.</AbstractText><AbstractText Label="SETTINGS">This study was conducted at a single academic institution with a prospectively maintained hereditary colorectal cancer database between 1995 and 2015.</AbstractText><AbstractText Label="PATIENTS">All patients with familial polyposis (total 345) who underwent either proctocolectomy with a pouch or colectomy with an ileorectal anastomosis during the study period and met inclusion criteria were selected.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The development of symptomatic abdominal desmoid disease was the primary end point. Associations between desmoid formation and resection type, surgical approach, and other patient factors were analyzed.</AbstractText><AbstractText Label="RESULTS">A total of 172 (49%) patients underwent proctocolectomy/ileoanal pouch, whereas 173 (51%) underwent total colectomy/ileorectal anastomosis. Overall, 100 (28.9%) developed symptomatic desmoids after surgery. On univariable analysis, open surgery and pouch surgery were associated with desmoid development, along with extracolonic manifestations, family history of desmoids, mutation location, and a high desmoid risk score. On multivarible analysis, proctocolectomy with pouch was most strongly associated with desmoid disease ( p &lt; 0.01).</AbstractText><AbstractText Label="LIMITATIONS">This study was limited by its retrospective nature, the lack of uniform desmoid screening, and the variable duration of follow-up. Unanalyzed confounding factors include polyposis severity and number of surgeries.</AbstractText><AbstractText Label="CONCLUSIONS">Patients with polyposis who underwent total proctocolectomy with pouch by any approach had significantly greater risk of developing desmoid disease than total colectomy with ileorectal anastomosis, even when accounting for other risk factors. See Video Abstract at http://links.lww.com/DCR/B822 .RESULTADOS DE LOS PACIENTES SOMETIDOS A RESECCI&#xd3;N INTESTINAL ELECTIVA ANTES Y DESPU&#xc9;S DE LA IMPLEMENTACI&#xd3;N DE UN PROGRAMA DE DETECCI&#xd3;N Y TRATAMIENTO DE ANEMIA.</AbstractText><AbstractText Label="ANTECEDENTES">Se sabe que los pacientes an&#xe9;micos que se someten a una cirug&#xed;a electiva de c&#xe1;ncer colorrectal tienen tasas significativamente m&#xe1;s altas de complicaciones posoperatorias y peores resultados.</AbstractText><AbstractText Label="OBJETIVO">Mejorar las tasas de detecci&#xf3;n y tratamiento de la anemia en pacientes sometidos a resecciones electivas de colon y recto a trav&#xe9;s de una iniciativa de mejora de calidad.</AbstractText><AbstractText Label="DISEO">Comparamos una cohorte hist&#xf3;rica de pacientes antes de la implementaci&#xf3;n de nuestro programa de detecci&#xf3;n de anemia y mejora de la calidad del tratamiento con una cohorte prospectiva despu&#xe9;s de la implementaci&#xf3;n.</AbstractText><AbstractText Label="ENTORNO CLINICO">Hospital de atenci&#xf3;n terciaria.</AbstractText><AbstractText Label="PACIENTES">Todos los pacientes adultos con un nuevo diagn&#xf3;stico de c&#xe1;ncer de colon o recto sin evidencia de enfermedad metast&#xe1;sica entre 2017 y 2019.</AbstractText><AbstractText Label="INTERVENCIONES">Detecci&#xf3;n de anemia y programa de mejora de la calidad del tratamiento.</AbstractText><AbstractText Label="PRINCIPALES MEDIDAS DE RESULTADO">El resultado primario fue el costo hospitalario por ingreso.</AbstractText><AbstractText Label="RESULTADOS">Un total de 84 pacientes se sometieron a resecci&#xf3;n electiva de colon o recto antes de la implementaci&#xf3;n de nuestro proyecto de mejora de calidad de la anemia y 88 pacientes se sometieron a cirug&#xed;a despu&#xe9;s. En la cohorte previa a la implementaci&#xf3;n, 44/84 (55,9 %) presentaban anemia en comparaci&#xf3;n con 47/99 (54,7 %) en la cohorte posterior a la implementaci&#xf3;n. Las tasas de detecci&#xf3;n (25 % a 86,4 %) y tratamiento (27,8 % a 63,8 %) aumentaron significativamente en la cohorte posterior a la implementaci&#xf3;n. El costo total medio por admisi&#xf3;n se redujo significativamente en la cohorte posterior a la implementaci&#xf3;n (costo medio $16 827 vs. $25 796, p = 0,004); esta reducci&#xf3;n significativa se observ&#xf3; incluso despu&#xe9;s de ajustar los factores de confusi&#xf3;n relevantes (proporci&#xf3;n de medias: 0,74, IC del 95 %: 0,65 a 0,85). El v&#xed;nculo mec&#xe1;nico entre el tratamiento de la anemia y la reducci&#xf3;n de costos sigue siendo desconocido. No hubo diferencias significativas en las tasas de transfusi&#xf3;n de sangre, complicaciones o mortalidad entre los grupos.</AbstractText><AbstractText Label="LIMITACIONES">El dise&#xf1;o de antes y despu&#xe9;s est&#xe1; sujeto a sesgos temporales y de selecci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES">Demostramos la implementaci&#xf3;n exitosa de un programa de detecci&#xf3;n y tratamiento de anemia. Este programa se asoci&#xf3; con un costo por admisi&#xf3;n significativamente reducido. Este trabajo demuestra el valor y los beneficios posibles de la implementaci&#xf3;n de un programa de detecci&#xf3;n y tratamiento de la anemia. Consulte Video Resumen en http://links.lww.com/DCR/C15 . (Traducci&#xf3;n- Dr. Francisco M. Abarca-Rendon ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sommovilla</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liska</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalady</LastName><ForeName>Matthew F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sklow</LastName><ForeName>Bradford</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>Carol A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leach</LastName><ForeName>Brandie H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Medicine Institute, Cleveland Clinic, Cleveland Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Scott R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sanford R. Weiss, M.D. Center for Hereditary Colorectal Neoplasia, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Church</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D011125" MajorTopicYN="Y">Adenomatous Polyposis Coli</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018222" MajorTopicYN="Y">Desmoid Tumors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34840307</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000002172</ArticleId><ArticleId IdType="pii">00003453-202211000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Quintini C, Ward G, Shatnawei A, et al. Mortality of intra-abdominal desmoid tumors in patients with familial adenomatous polyposis: a single center review of 154 patients. Ann Surg. 2012;255:511&#x2013;516.</Citation></Reference><Reference><Citation>de Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I. Evaluating causes of death in familial adenomatous polyposis. J Gastrointest Surg. 2010;14:1943&#x2013;1949.</Citation></Reference><Reference><Citation>Xhaja X, Church J. Small bowel obstruction in patients with familial adenomatous polyposis related desmoid disease. Colorectal Dis. 2013;15:1489&#x2013;1492.</Citation></Reference><Reference><Citation>Xhaja X, Church J. Enterocutaneous fistulae in familial adenomatous polyposis patients with abdominal desmoid disease. Colorectal Dis. 2013;15:1238&#x2013;1242.</Citation></Reference><Reference><Citation>Joyce M, Mignanelli E, Church J. Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease. Dis Colon Rectum. 2010;53:327&#x2013;332.</Citation></Reference><Reference><Citation>Bolshinsky V, Xhaja X, Halleran DR, Church J. Superior mesenteric artery pseudoaneurysms in patients with familial adenomatous polyposis-associated intra-abdominal desmoids: case series. Dis Colon Rectum. 2019;62:721&#x2013;726.</Citation></Reference><Reference><Citation>Church J, Lynch C, Neary P, LaGuardia L, Elayi E. A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum. 2008;51:897&#x2013;901.</Citation></Reference><Reference><Citation>Penel N, Chibon F, Salas S. Adult desmoid tumors: biology, management and ongoing trials. Curr Opin Oncol. 2017;29:268&#x2013;274.</Citation></Reference><Reference><Citation>Bertario L, Russo A, Sala P, et al.; Hereditary Colorectal Tumours Registry. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer. 2001;95:102&#x2013;107.</Citation></Reference><Reference><Citation>Nieuwenhuis MH, Lefevre JH, B&#xfc;low S, et al. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum. 2011;54:1229&#x2013;1234.</Citation></Reference><Reference><Citation>Carothers AM, Rizvi H, Hasson RM, et al. Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors. Cancer Res. 2012;72:346&#x2013;355.</Citation></Reference><Reference><Citation>Enzo MV, Rastrelli M, Rossi CR, Hladnik U, Segat D. The Wnt/&#x3b2;-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. Mol Cell Ther. 2015;3:1.</Citation></Reference><Reference><Citation>da Luz Moreira A, Church JM, Burke CA. The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum. 2009;52:1481&#x2013;1486.</Citation></Reference><Reference><Citation>Saito Y, Hinoi T, Ueno H, et al. Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis: multicenter retrospective cohort study in Japan. Ann Surg Oncol. 2016;23(suppl 4):559&#x2013;565.</Citation></Reference><Reference><Citation>Xie M, Chen Y, Wei W, et al. Does ileoanal pouch surgery increase the risk of desmoid in patients with familial adenomatous polyposis? Int J Colorectal Dis. 2020;35:1599&#x2013;1605.</Citation></Reference><Reference><Citation>Vogel J, Church JM, LaGuardia L. Minimally invasive pouch surgery predisposes to desmoid tumor formation in patients with familial adenomatous polyposis. Dis Colon Rectum 2005; 48: 662&#x2013;3.</Citation></Reference><Reference><Citation>Speake D, Evans DG, Lalloo F, Scott NA, Hill J. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg. 2007;94:1009&#x2013;1013.</Citation></Reference><Reference><Citation>Elayi E, Manilich E, Church J. Polishing the crystal ball: knowing genotype improves ability to predict desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum. 2009;52:1762&#x2013;1766.</Citation></Reference><Reference><Citation>Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol. 1996;122:135&#x2013;140.</Citation></Reference><Reference><Citation>Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res. 1993;53:5079&#x2013;5082.</Citation></Reference><Reference><Citation>van Duijvendijk P, Slors JF, Taat CW, Oosterveld P, Vasen HF. Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. Ann Surg. 1999;230:648&#x2013;654.</Citation></Reference><Reference><Citation>Konishi T, Ishida H, Ueno H, et al. Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study. Int J Clin Oncol. 2016;21:953&#x2013;961.</Citation></Reference><Reference><Citation>Soravia C, Klein L, Berk T, O&#x2019;Connor BI, Cohen Z, McLeod RS. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum. 1999;42:1028&#x2013;1033.</Citation></Reference><Reference><Citation>Sinha A, Burns EM, Latchford A, Clark SK. Risk of desmoid formation after laparoscopic versus open colectomy and ileorectal anastomosis for familial adenomatous polyposis. BJS Open. 2018;2:452&#x2013;455.</Citation></Reference><Reference><Citation>Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet. 1998;62:1290&#x2013;1301.</Citation></Reference><Reference><Citation>Hartley JE, Church JM, Gupta S, McGannon E, Fazio VW. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum. 2004;47:334&#x2013;339.</Citation></Reference><Reference><Citation>Ozdemir Y, Kalady MF, Aytac E, et al. Anal transitional zone neoplasia in patients with familial adenomatous polyposis after restorative proctocolectomy and IPAA: incidence, management, and oncologic and functional outcomes. Dis Colon Rectum. 2013;56:808&#x2013;814.</Citation></Reference><Reference><Citation>Church J. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum. 2005;48:1708&#x2013;1713.</Citation></Reference><Reference><Citation>Herzig D, Hardiman K, Weiser M, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of inherited polyposis syndromes. Dis Colon Rectum. 2017;60:881&#x2013;894.</Citation></Reference><Reference><Citation>G&#xfc;nther K, Braunrieder G, Bittorf BR, Hohenberger W, Matzel KE. Patients with familial adenomatous polyposis experience better bowel function and quality of life after ileorectal anastomosis than after ileoanal pouch. Colorectal Dis. 2003;5:38&#x2013;44.</Citation></Reference><Reference><Citation>Olsen K&#xd8;, Juul S, B&#xfc;low S, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg. 2003;90:227&#x2013;231.</Citation></Reference><Reference><Citation>Feinberg SM, Jagelman DG, Sarre RG, et al. Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis. Dis Colon Rectum. 1988;31:169&#x2013;175.</Citation></Reference><Reference><Citation>Burke CA, Dekker E, Lynch P, et al. Eflornithine plus sulindac for prevention of progression in familial adenomatous polyposis. N Engl J Med. 2020;383:1028&#x2013;1039.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33342185</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1087-2108</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Dermatology online journal</Title><ISOAbbreviation>Dermatol Online J</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13030/qt82j1s7k4</ELocationID><Abstract><AbstractText>Subcutaneous fat necrosis of the newborn is a rare lobular panniculitis. It is characteristic of term or post-term neonates with a history of perinatal compromise or maternal gestational pathology. The cutaneous manifestations consist of erythematous and indurated subcutaneous plaques and nodules located over the dorsal region and the shoulders. Diagnosis is clinical and pathological. Histopathological findings include lobular panniculitis with a lymphohistiocytic inflammatory infiltrate with few neutrophils, fatty necrosis, deposition of radial needle-shaped crystals in the adipocytes, and possible calcification and hemorrhage. The cutaneous ultrasound shows hyperechoic and avascular subcutaneous cellular tissue and acoustic shadows may appear corresponding to calcifications. The clinical differential diagnosis includes sclerema neonatorum and post-corticosteroid panniculitis. Histologically crystal-forming panniculitis conditions are in the differential diagnosis. The disease is usually self-limited but complications such as hypercalcemia, hypoglycemia, hypertriglyceridemia, thrombocytopenia, and anemia may occur. Complications should be ruled out and treated at diagnosis and during follow-up. The most important complication is hypercalcemia.La necrosis grasa subcut&#xe1;nea neonatal es una paniculitis lobulillar infrecuente. Es caracter&#xed;stica de neonatos a t&#xe9;rmino o post&#xe9;rmino con antecedentes de sufrimiento perinatal o patolog&#xed;a gestacional materna. Las manifestaciones cut&#xe1;neas consisten en placas y n&#xf3;dulos subcut&#xe1;neos eritematosos e indurados localizados preferentemente en la regi&#xf3;n dorsal y los hombros. El diagn&#xf3;stico es cl&#xed;nicopatol&#xf3;gico. Los hallazgos histopatol&#xf3;gicos comprenden una paniculitis lobulillar con un infiltrado inflamatorio linfohistiocitario con escasos neutr&#xf3;filos, necrosis grasa, dep&#xf3;sito de cristales radiados en los adipocitos y posibles focos de calcificaci&#xf3;n y hemorragia. En la ecograf&#xed;a cut&#xe1;nea se observa hiperecogenicidad y avascularizaci&#xf3;n del tejido celular subcut&#xe1;neo y pueden aparecer sombras ac&#xfa;sticas posteriores que se correspondencon calcificaciones. El diagn&#xf3;stico diferencial cl&#xed;nico se debe realizar con el escleredema neonatorum y la paniculitis postesteroidea, e histol&#xf3;gicamente con las paniculitis con formaci&#xf3;n de cristales. La enfermedad suele ser autolimitada pero pueden aparecer complicaciones como la hipercalcemia, la hipoglucemia, la hipertrigliceridemia, latrombocitopenia y la anemia. Las complicaciones deben ser descartadas y tratadas en el diagn&#xf3;stico y durante el seguimiento. La complicaci&#xf3;n m&#xe1;simportante es la hipercalcemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guillen-Climent</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nico Universitario, Valencia. santigc85@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a V&#xe1;zquez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Est&#xe9;banez</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Pons Benavent</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Folch Briz</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Gil Viana</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>S&#xe1;ez-Mart&#xed;n</LastName><ForeName>Luis Carlos</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Mar&#xed;a Mart&#xed;n</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ram&#xf3;n Quiles</LastName><ForeName>Mar&#xed;a Dolores</ForeName><Initials>MD</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Subcutaneous fat necrosis of the newborn: clinical and histopathological review and use of cutaneous ultrasound Necrosis grasa subcut&#xe1;nea del reci&#xe9;n nacido: revisi&#xf3;n cl&#xed;nica e histopatol&#xf3;gica y utilidad de la ecograf&#xed;a cut&#xe1;nea.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dermatol Online J</MedlineTA><NlmUniqueID>9610776</NlmUniqueID><ISSNLinking>1087-2108</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001415" MajorTopicYN="N">Back</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009333" MajorTopicYN="N">Neck</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050151" MajorTopicYN="N">Subcutaneous Fat</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>20</Day><Hour>22</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33342185</ArticleId><ArticleId IdType="pii">13030/qt82j1s7k4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34543559</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2448-5667</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>4</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Revista medica del Instituto Mexicano del Seguro Social</Title><ISOAbbreviation>Rev Med Inst Mex Seguro Soc</ISOAbbreviation></Journal><ArticleTitle>Still's disease: a rare condition, in a patient of unusual age.</ArticleTitle><Pagination><StartPage>517</StartPage><EndPage>521</EndPage><MedlinePgn>517-521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/RMIMSS.M20000078</ELocationID><Abstract><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">Cuando inicia en el adulto, la enfermedad de Still es de mayor prevalencia en cauc&#xe1;sicos y entre los 16 y 35 a&#xf1;os. De etiolog&#xed;a desconocida, se asocia a HLA-II, DR2, 4 y 7, y Bw35. El comienzo de los s&#xed;ntomas es agudo, con fiebre en agujas, asociada a exantema en las extremidades y el tronco, maculopapular, eritematoso y evanescente, pruriginoso, con fen&#xf3;meno de Koebner. Presenta artralgias y artritis con un patr&#xf3;n poliarticular, sim&#xe9;trico y migratorio, mialgias y adenopat&#xed;as. El 90% de los pacientes presentan anemia, leucocitosis con neutrofilia y trombocitosis asociada a la actividad, as&#xed; como elevaci&#xf3;n de transaminasas y ferritina &gt; 2000. El factor reumatoide y los anticuerpos antinucleares son negativos. El objetivo del presente trabajo es presentar un caso de enfermedad de Still que se sale del patr&#xf3;n habitual de manifestaci&#xf3;n.</AbstractText><AbstractText Label="CASO CL&#xcd;NICO" NlmCategory="UNASSIGNED">Mujer de 56 a&#xf1;os, inicia con exantema -maculopapular, eritematoso, pruriginoso, en zona periorbitaria -bilateral, t&#xf3;rax anterior, regi&#xf3;n gl&#xfa;tea bilateral y zonas de extensi&#xf3;n de codos y rodillas, que respetan el abdomen. Fiebre vespertina de 39 &#xb0;C, con artralgias de codos, mu&#xf1;ecas y rodillas, y mialgias, con faringe hiper&#xe9;mica. Despu&#xe9;s de descartar procesos infecciosos, neopl&#xe1;sicos y autoinmunitarios, y de acuerdo con los criterios de Yamaguchi y Fautrel, se diagnostic&#xf3; enfermedad de Still.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Este caso se presenta por la baja prevalencia de la enfermedad de Still y porque en el grupo etario de nuestra paciente no es habitual su presentaci&#xf3;n. Los -antecedentes familiares y el cuadro cl&#xed;nico sugestivo obligaron a descartar la presencia de otros procesos m&#xf3;rbidos, toda vez que el diagn&#xf3;stico de enfermedad de Still es de exclusi&#xf3;n.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adult-onset on Still&#x2019;s disease is common in Caucasians, between 16 and 35 years. Its cause is unknown, but it is associated with HLA-II, DR2, 4, 7 and Bw35. First symptoms are acute; fever in needles associated with exanthema in extremities and maculopapular trunk, erythematous and evanescent, pruritic with Koebner phenomenon. Patients present arthralgias and arthritis with a polyarticular, symmetrical and migratory pattern; myalgias and adenopathies. 90% of patients have anemia, leukocytosis with neutrophilia and thrombocytosis associated with the activity. Elevation of transaminases and ferritin greater than 2000. The rheumatoid factor and antinuclear antibodies are negative. The aim of this article is to present a case report of Still&#x2019;s Disease whose pattern of appearance is uncommon.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="METHODS">A 56-year-old woman presented papular macular, erythematous, pruritic exanthema, in the bilateral peri-orbital area, anterior thorax, bilateral gluteal region, and elbow and knee extensions, while respecting abdomen. In addition, evening fever of 39 &#xb0;C with arthralgias in elbows, wrists, and knees, myalgias, and hyperemic pharynx were manifested. According to the criteria of Yamaguchi and Fautrel, and after ruling out infectious, neoplastic, autoimmune processes, Still&#x2019;s disease was concluded.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This case is presented due to the low prevalence of Still&#x2019;s disease and its presentation is not usual in the age group of our patient. The family history and very &#xad;indicative clinical pictures forced us to rule out the presence of other morbid processes, while reinforcing the diagnosis of Still&#x2019;s disease, since it is by exclusion.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2020 Revista Medica del Instituto Mexicano del Seguro Social.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olvera-Acevedo</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Centro M&#xe9;dico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Departamento de Medicina Interna. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurtado-D&#xed;az</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Centro M&#xe9;dico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Departamento de Medicina Interna. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinoza-S&#xe1;nchez</LastName><ForeName>Mar&#xed;a Lucero</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Centro M&#xe9;dico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Departamento de Medicina Interna. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Enfermedad de Still: padecimiento poco frecuente en paciente de edad poco habitual.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Rev Med Inst Mex Seguro Soc</MedlineTA><NlmUniqueID>101243727</NlmUniqueID><ISSNLinking>0443-5117</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Still&#x2019;s Disease</Keyword><Keyword MajorTopicYN="N">Adult-Onset</Keyword><Keyword MajorTopicYN="N">Arthritis</Keyword><Keyword MajorTopicYN="N">Artritis</Keyword><Keyword MajorTopicYN="N">Enfermedad de Still del Adulto</Keyword><Keyword MajorTopicYN="N">Fever</Keyword><Keyword MajorTopicYN="N">Fiebre</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>20</Day><Hour>17</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34543559</ArticleId><ArticleId IdType="doi">10.24875/RMIMSS.M20000078</ArticleId><ArticleId IdType="pii">j58/4/517</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>